Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G. Willett, Lance L. Munn, Ricky T. Tong et al.|Nature Medicine|2004Cited by 2k
Erratum: CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancerChristopher G. Willett, Yves Boucher, Emmanuelle di Tomaso et al.|Nature Medicine|2004Cited by 21
Case 34-2003Daniel C. Chung, Kristen M. Shannon, Mari Mino|New England Journal of Medicine|2003Cited by 9